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Chapter 3
Micro-array expression analysis of a cell
line stably transfected with 3p21.3
sequences indicates the occurrence of
trans-regulation between originally










Department of Medical Genetics, University Medical Center Groningen, Groningen,
The Netherlands
ABSTRACT
We have previously found a significant reduction of tumour growth upon injection in
nude mice of cells stably transfected with a PAC containing a centromeric sequence
of the 3p21.3 region commonly deleted in lung cancer, as compared to the tumour
growth after injection of the parental cell line. To evaluate the transcriptional
consequences of the introduction of this PAC into the cell line, we compared the
gene expression levels of the transfectants with the gene expression levels of the
parental cell line, using micro-array expression analysis. A complication, however, is
that injection of one of two transfectants with vector only sequences also led to a
significantly diminished tumour growth in nude mice and that array-CGH revealed
that all transfected clones tested had an increased chromosomal instability
compared to the parental cell line. When we compared the gene expression levels of
transfectant-1 containing the PAC with those of the parental cell line and did the
same for transfectant-2 containing the PAC and the parental cell line, we found that
only a small proportion of significantly differentially expressed genes were present in
both comparisons. By comparing the gene expression data with the previously
obtained array-CGH data, we were able to see a strong concordance of regions with
DNA copy number changes –that varied between the transfectants- and regions with
transcriptional changes. This explains why only a small overlap occurred between
differentially expressed genes of both transfectants with the PAC. In addition, we
found that the 3p21.3 genes CACNA2D2 and TUSC4 were higher expressed in
transfectants with the PAC than in the parental cell line. These two genes are not
located on the PAC, but are normally in the 3p21.3 region neighbours of CYB561D2
and PL6, that are located on the PAC. This suggests the occurrence of trans-




A 3p21.3 region containing 19 genes is considered as a lung cancer critical region
with tumour suppressor activity (Wei ., 1996; Lerman and Minna, 2000). In a
previous study, we covered this region with overlapping P1 artificial chromosomes
(PAC) and used these to transfect cells from GLC45, a small cell lung cancer
(SCLC) cell line which readily causes tumours in nude mice. We found a significant
reduction of tumour growth upon injection in nude mice of cells stably transfected
with PAC 185A4, containing a centromeric part of the 3p21.3 critical region, as
compared to the tumour growth after injection of the parental cell line (A ter Elst, BE
Hiemstra, P van der Vlies, W Kamminga, AY van der Veen, I Davelaar, G J te
Meerman, F Gerbens, K Kok, CHCM Buys, submitted). Injection of one of two
transfected clones with vector only sequences also led, however, to a significant
reduction of tumour growth upon injection in nude mice. By array-CGH, we found
multiple gains and losses in the transfectants with PAC185A4, as compared to the
parental cell line. In both transfectants containing vector only sequences also
multiple gains and losses were found, even though one of these transfectants did not
show a significantly reduced tumour growth upon injection into nude mice. Although
the transfectants had some gains and losses in common, the genomic profile of
losses and gains on the whole differed for each of the transfectants.
We wanted to evaluate the transcriptional consequences of the introduction
of PAC 185A4. We, therefore, compared gene expression levels of the transfectants






The SCLC cell line GLC45 (Naylor et al., 1998) was cultured in RPMI-1640 (GIBCO -
Invitrogen Inc, Carlsbad, Ca, USA) supplemented with 15% foetal calf serum and 0.1
mM sodium pyruvate, 0.1 mM HEPES, penicillin/streptomycin, glutamine and 250
µg/ml amphotericin B (all from GIBCO – Invitrogen)  at 37° C in a 5% CO2 incubator.
RNA isolation
Total RNA was isolated with the RNeasy mini kit including DNAse treatment
(Qiagen, Valencia, CA, USA) from the same cell population as used for injection of
nude mice in the tumourigenicity tests. The RNA yield and purity were determined
spectrophotometrically by measuring the absorbance at 260 nm and 280 nm. RNA
integrity was checked on 1% agarose gels.
Messenger-RNA amplification and Cy-dye coupling
Linear amplification of mRNA was performed essentially according to a protocol of
the Dutch Cancer Institute (www.nki.l.nl/nkidep/pa/microarray/protocols.html). Briefly,
amplification started with first strand cDNA synthesis from 2 µg of total RNA, using
Superscript II RT-polymerase (GIBCO) and a specific oligo(dT) primer containing a
17 bp T7 polymerase recognition site (5'-GGCCAGTGAATTGTAATACGACTCACT
ATAGGGAGGCGGT-24-3') (Eurogentec, Seraing, Belgium). After second strand
synthesis, double-stranded cDNA was purified with the Qiaquick PCR purification kit
(Qiagen) and the yield was determined spectrophotometrically. In vitro transcription
was performed with the T7 Megascript kit (Ambion, Huntingdon, UK) as described by
the manufacturer and aminoallyl-UTP (Ambion) was incorporated as described by ‘t
Hoen et al (2003). Amplified RNA (aRNA) was purified with the RNA clean up
protocol (Qiagen). Five µg of aRNA was labelled by coupling monoreactive Cyanine
3 or Cyanine 5 fluorophores (Amersham Biosciences, Little Chalfont,
Buckinghamshire, UK) to the aminoallyl-modified nucleotides. Labelled aRNA was
separated from unincorporated Cyanine 3 or Cyanine 5 molecules using Microspin
G50 size exclusion columns (Millipore Corp, Amsterdam, The Netherlands) as
described by the manufacturer.
Experimental design for gene expression profiling. A balanced design
including dye swap and self-self hybridisations was applied for micro-array based
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dual-colour gene expression analysis for both the transfectants with PAC185A4 and
the pPAC4 vector as described in Table 1.
Table 1. Experimental design of the dual-colour gene expression array analyses.
Experiment Slide # Cyanine 5 Cyanine 3
PAC 185A4 1 GLC45 (230904)a GLC45 (230904)
2 GLC45 + PAC 185A4 transfectant-1 GLC45 + PAC 185A4 transfectant-1
3 GLC45 + PAC 185A4 transfectant-2 GLC45 + PAC 185A4 transfectant-2
4 GLC45 (230904) GLC45 + PAC 185A4 transfectant-1
5 GLC45 + PAC 185A4 transfectant-1 GLC45 (230904)
6 GLC45 (230904) GLC45 + PAC 185A4 transfectant-2
7 GLC45 + PAC 185A4 transfectant-2 GLC45 (230904)
pPAC4 8 GLC45 (150704) a GLC45 (150704)
9 GLC45 + pPAC4 transfectant-1 GLC45 + pPAC4 transfectant-1
10 GLC45 + pPAC4 transfectant-2 GLC45 + pPAC4 transfectant-2
11 GLC45 (150704) GLC45 + pPAC4 transfectant-1
12 GLC45 + pPAC4 transfectant-1 GLC45 (150704)
13 GLC45 (150704) GLC45 + pPAC4 transfectant-2
14 GLC45 + pPAC4 transfectant-2 GLC45 (150704)
a  Different subcultures of GLC45. By array-CGH no chromosomal alterations were found between both 4-
week subcultures (our previous study).
Micro-array slides and hybridisation
In-house manufactured human oligonucleotide arrays were used containing the
Qiagen/operon 21,329 70-mer human gene-specific oligonucleotide set version 2.1
extended with 4,000 negative and positive control features. The oligonucleotides
were printed in a concentration of 10 pM on Ultra-GAPS amino-silane coated slides
(Corning BV. Life Sciences, New York, USA) using BioRobotics 10K quill pins with
the MicroGrid spotter (Isogen). Blocking, prehybridisation and hybridisation were
performed as described by Hegde et al. (2000) with some modifications. In short,
slides were blocked with ethanolamine at 52°C during 1 h. Prehybridisation was
done with prewarmed prehybridisation buffer containing 0.5% bovine serum albumin
(Sigma-Alldrich, St. Louis, MO, USA) at 52°C during 45 min Subsequently, the slides
were washed six times with preheated water (52°C), dried by centrifugation at 800
rpm during 3 min and immediately used for hybridisation. The hybridisation sample
consisted of the fluorescently labelled probe mixture and 30 µg poly-A (Sigma
Alldrich) mixed with an equal volume of preheated (52°C) two times hybridisation
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buffer. This hybridisation sample was heated at 95°C for 3 min before it was applied
to the preheated slides. Hybridisation was performed in hybridisation chambers
(Telechem International Inc, Sunnyvale, CA, USA) in a water bath at 52°C in the
dark for approximately 48 h. Subsequently, slides were washed with 5 wash
solutions under agitation: 1xSSC/0.2% SDS at 52ºC; 0.1xSSC/0.2% SDS at 52ºC;
0.1xSSC at 52º; 0.1xSSC at room temperature and 0.01xSSC at room temperature.
Each wash step lasted 5 minutes. Finally slides were dried by centrifugation at 800
rpm during 3 min and scanned with an Affymetrix GMS428TM array scanner.
Micro-array data analysis
Fluorescent signal intensity data for each spot and for each fluorophore were
extracted from the scanned images of each micro-array slide using ImaGene version
5.6 (BioDiscovery, El Segundo, California, USA). Signal intensity data were log
transformed and for each spot the Cyanine 5 signal intensity/Cyanine 3 signal
intensity ratio was determined and subjected to print-tip lowess intensity dependent
normalisation using the Limma package from the Bioconductor project in R
(http://bioinf.wehi.edu.au/limma). Since no dependency exists between both samples
('t Hoen et al., 2004), normalised log-ratios were back transformed to log intensities.
Further data analysis was performed using BRB ArrayTools v3.2 developed by Dr.
Richard Simon and Amy Peng Lam (http://linus.nci.nih.gov/~brb/download.html).
Basically, data was vigorously filtered to exclude control spots, empty spots, spots
with a high between pixel intensity variability and spots designated as bad by eye.
Genes that had more than 50% missing data across all observations were excluded
from the analysis. Genes significantly differentially expressed between transfectants
and the parental cell line were identified by a F-test using a randomised variance
model and accounting for replicate readings of the same sample. Moreover, a
multivariate permutation test (Reiner et al., 2003) was applied to account for a false
discovery rate of no more than 10% in the set of significantly differentially expressed
genes. Regions with correlated expression biases for gene expression array data
and regions showing gains and losses for array-CGH data were determined using
the cluster-along-chromosomes procedures as implemented in CGH-miner (Wang et
al., 2005). The false discovery rate was restricted to 1% as compared to well-
matched self-self hybridisations for expression array and three normal-normal
hybridisations for array-CGH. Before clustering along individual chromosome arms,
the signal intensities were smoothed with a moving average window of 7 gene-
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specific oligonucleotides for gene expression array data and 3 BACs for array-CGH
data.
Real-time RT-PCR
For quantitative real-time RT-PCR, first strand cDNA was generated by using
Ready-To-GoTM You-Primed First-Strand Beads (Amersham Biosciences) and an
oligo-dT primer (Eurogentec) as described by the manufacturer. Table 2 shows the
primers for each gene that were designed with the program Primer Express (Applied
Biosystems, Foster City, CA, USA). For each sample the PCR product yield was
analysed in real time in triplicate in a final volume of 20 ul in a 384-well plate with the
ABI Prism 7700 Sequence Detection System (Applied Biosystems). Finally, PCR
products were checked by electrophoresis in a 2% agarose gel. Real-time data was
analysed with the Sequence Detection System software (SDS 2.1.1, Applied
Biosystems). For each gene the threshold cycle value (Ct) of every sample was
extracted from the amplification plots. The difference in expression between the
transfectant clone and the parental cell line sample was determined for each gene,
using the ∆∆ median threshold cycle number (Ct) method. The corresponding fold
change in expression was calculated by the formula 2-∆∆Ct (Livak and Schmittgen,
2001).
Table 2. Primer sequences for six genes located in the 3p21.3 critical region and for
B2M used as a reference in real-time RT-PCR.






QRT-CYB561D2 CYB561D2 GCCCTGTCCTCACCAGCTT GAGCTCATGGTTGGATCCTCTT
QRT-PL6 PL6 CTCCCCCGACGCTGTAACT TGGAGTAGCTGAGAGGATGTCAAG
QRT-CACNA2D2 CACNA2D2 CCACCGTTGCAGATTTCCTT TGGTAGATGAGGCCGTAGAGAAG
QRT-TUSC4-2 TUSC4 GCAAGAGGCATGTCTATCCTACGT CAGGGCTCAGGCTGCAGTATA
B2M B2M TGACTTTGTCACAGCCCAAGATA AATGCGGCATCTTCAAACCT
Statistics
Statistical significance was determined by analysis of variance (ANOVA) with





To evaluate the transcriptional consequences of the introduction of PAC 185A4 and
vector only sequences into GLC45 we compared the gene expression level of the
transfectants with the gene expression level of the parental cell line GLC45, using
micro-array expression analysis. Since the genomic profile of losses and gains
differed for each of the transfectants, we decided to analyse each transfectant
separately, comparing it to the parental cell line. These analyses revealed that 502
and 128 genes were significantly (p<0.0001) differentially expressed between
GLC45 and transfectants-1 and 2 with PAC 185A4, respectively. For transfectants
containing vector only sequences, 175 and 214 genes appeared to be significantly
(p<0.0001) differentially expressed between the parental cell line and transfectants-1
and 2, respectively.
Figure 1 shows an overlap of 45 genes between the differentially expressed
genes of transfectants-1 and 2 containing PAC 185A4 and an overlap of a more or
less similar size of 37 genes between transfectants-1 and 2 with vector only
sequences. Of these 45 and 37 genes, 26 and 22, respectively, were either higher
expressed in both transfectants than in the parental cell line or lower expressed in
both transfectants. In our previous study a reduced tumour growth upon injection into
nude mice, as compared to the tumour growth after injection of the parental cell line
was found for both transfectants with PAC 185A4 and for one of the transfectants
with vector only sequences. Therefore, we also determined the overlap of
differentially expressed genes between these three transfectants. Three genes,
LOC145957, FOS and KYNU are similarly expressed in all three comparisons. FOS
is higher expressed in each of the three transfectants, LOC145957 and KYNU are
lower expressed in each of the three transfectants. Both FOS and KYNU did not
occur in the list of significantly differentially expressed genes of the transfectant
which did not show a significantly reduced tumour growth upon injection into nude




Correspondence between DNA copy number alterations and gene expression
We compared the previously obtained CGH-array data with the comparative gene
expression array data. Chromosomal plots revealed a strong concordance between
regions with DNA copy number changes and regions with transcriptional changes
(Fig. 2). A higher copy number corresponded with a higher expression, a lower copy
number with a lower expression.
Figure 1. Overlap of significantly (p<0.0001) differentially expressed genes from the comparisons
performed in this study.
Genes from each overlap are listed in the blocks. Genes in bold are either elevated or repressed in both
transfectants as compared to the parental cell line GLC45. Genes that are underlined are part of a
gained region in both transfectants. A: Comparison of transfectant-1 with PAC 185A4 as compared to the
parental cell line (502 genes) and transfectant-2 with PAC 185A4 as compared to the parental cell line
(128 genes) B: Comparison of transfectant-1 with PAC vector only sequences as compared to the
parental cell line (175 genes) and transfectant-2 with PAC vector only sequences as compared to the
parental cell line (214 genes) C: Comparison of all transfectants that showed a reduction of tumour
growth upon injection into nude mice, i.e. transfectants-1 and 2 containing PAC 185A4 and transfectant-
2 containing vector only sequences.
Micro-array expression analysis
89
Figure 2. Correlated changes of genomic copy number and gene transcription in PAC transfectants
compared to the parental cell line GLC45.
The panels show chromosomal profile log ration plots of array-CGH and corresponding array-based gene
expression data. Regions with significant changes in either the array-CGH data (gains and losses) or
gene expression data as obtained by the cluster-along-chromosomes (CLAC) procedure are indicated in
each plot by horizontal bars.
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Expected higher expression of PAC 185A4 genes
PAC 185A4 contains the genes PL6 and CYB561D2. In both transfectants with PAC
185A4, CYB561D2 and PL6 were higher expressed than in the parental cell line
(Fig. 3). CYB561D2 was 2.2 fold higher expressed in transfectant-1 with PAC 185A4
and 4.5 fold higher expressed in transfectant-2. For PL6 the fold changes were 2.7
and 6.7 for transfectants-1 and 2 with PAC 185A4, respectively compared to their
expression in the parental cell line.
Higher expression of originally neighbouring genes
An analysis of the expression profiles of the transfectants with PAC 185A4 revealed
that the originally neighbouring 3p21.3 genes (Fig. 4), TUSC4 (coding for tumour
suppressor candidate 4) and CACNA2D2 (encoding calcium channel voltage-
dependent, alpha 2/delta subunit 2) were each also higher expressed in one
transfectant with PAC 185A4 than in the parental cell line (Fig. 3).
Figure 3. Real-time RT-PCR
validation of transcriptional
changes in PAC transfectants as
compared to the parental cell line
GLC45 for four genes located in
the 3p21.3 critical region.
Bar charts show fold changes with
standard deviation. A: Expression
array B: Real-time RT-PCR.
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Validation of gene expression results for genes of the 3p21.3 critical region by
real time RT-PCR
To verify the gene expression levels for the genes of the 3p21.3 critical region by an
independent method, we performed real time RT-PCR analysis. For both of the
genes, CYB561D2 and PL6, located on PAC 185A4, and for both neighbouring
genes, CACNA2D2 and TUSC4, the results as obtained by either method were
highly concordant, as shown in Fig. 3.
Figure 4. A map of the genes,
CYB561D2 and PL6 located on PAC
185A4 and neighbouring genes,
TUSC4 and CACNA2D2 partly located
on PAC 185A4.





To evaluate the transcriptional consequences of the introduction into the SCLC cell
line GLC45 of PAC 185A4 containing two genes from the centromeric region of the
3p21.3 lung cancer critical region, we compared the gene expression level of the
transfectants with the gene expression level of the parental cell line by micro-array
expression analysis. After analysing every transfectant separately and comparing
the significantly differential expressed genes of transfectants with PAC 185A4 with
each other we found an overlap of 45 genes. The overlap of significantly differential
expressed genes between the transfectants with vector only was 37 genes. These
small overlaps might be a consequence of the earlier found genomic instability
causing large differences between the genomic profiles of the transfectants.
To evaluate if indeed the genomic instability has a strong influence on the
expression of the genes we compared the gene expression array data with the
previously obtained array-CGH data. We found that regions with DNA copy number
changes completely overlapped with regions containing transcriptional changes. A
high correlation between DNA copy number and gene expression has already been
suggested before (Pollack et al., 1999), but positional association has so far only
been found for highly amplified regions (Hughes et al., 2000; Kauraniemi et al.,
2001; Monni et al., 2001; Hyman et al., 2002). We found a highly consistent
association between deletions and low-level amplifications with lower and higher
gene transcription, respectively, in individual comparisons between a parental cell
line and derived transfectants.
As expected, also both genes located on PAC 185A4, PL6 and CYB561D2,
belonged to the significantly differentially expressed genes of transfectants with PAC
185A4 as compared to the parental cell line. Both genes were higher expressed in
the transfectants. In addition, we found that the two genes TUSC4 and CACNA2D2,
that flank CYB561D2 and PL6, respectively, in the original 3p21.3 sequence, were
also significantly higher expressed in the transfectants containing PAC 185A4, as
compared to the parental cell line. Despite the low fold changes found in the array
analysis, we were able to confirm the significant differences in expression by real-
time RT-PCR. None of these genes showed transcriptional changes in the
transfectants containing vector only sequences. Therefore, it is likely that the
observed higher expression of these genes is caused by sequences located on PAC
185A4. Since in the two transfectants, PAC 185A4 has integrated into the GLC45
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genome at different sites, not on the short arm of chromosome 3, this increased
expression of genes residing in the 3p21.3 lung cancer critical region, caused by
integrated PAC 185A4 sequences, must be due to trans-regulation.
Our results indicate that most of the differential gene expression found in the
transfectants is caused by genomic instability as compared to the parental cell line.
Among the 26 genes with a similar change of expression that occur in the overlap of
45 genes between the significantly expressed genes of the transfectants with PAC
185A4, the large majority is not in regions showing a strong correlation between
DNA copy number alterations and transcriptional changes. Among these may be
genes whose expression is directly or indirectly regulated by sequences present on
PAC 185A4.
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